Stenotrophomonas maltophilia: To be or not to be a cystic fibrosis pathogen

Current Opinion in Pulmonary Medicine

Volumn 18, Issue 6, 2012, Pages 628-631

  Hansen, Christine R ^a  

^a Mental Health Services CPH   (Denmark)

Author keywords

clinical outcome; cystic fibrosis; inflammation; pulmonary infection; Stenotrophomonas maltophilia

Indexed keywords

ASPERGILLUS FUMIGATUS; BACTERIAL COLONIZATION; BACTERIAL INFECTION; CYSTIC FIBROSIS; HUMAN; LUNG INFECTION; MYCOBACTERIUM ABSCESSUS; NONHUMAN; PSEUDOMONAS AERUGINOSA; PULSED FIELD GEL ELECTROPHORESIS; REVIEW; STENOTROPHOMONAS MALTOPHILIA; STENOTROPHOMONAS MALTOPHILIA INFECTION;

CROSS INFECTION; CYSTIC FIBROSIS; DRUG RESISTANCE, MULTIPLE; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; RESPIRATORY SYSTEM; STENOTROPHOMONAS MALTOPHILIA;

EID: 84867069683     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0b013e328358d4f8     Document Type: Review

References (17)

1. Boyle MP. Adult cystic fibrosis. JAMA 2007; 298:1787-1793.
2. Marchac V, Equi A, Le Bihan-Benjamin C, et al. Case-control study of Stenotrophomonas maltophilia acquisition in cystic fibrosis patients. Eur Respir J 2004; 23:98-102.
3. Colin AA, Rabin HR. Stenotrophomonas maltophilia in cystic fibrosis: guilty or innocent? Am J Respir Crit Care Med 2011; 183:564-566.
4. Høiby N, Pressler T. Emerging pathogens in cystic fibrosis. In: Webb AK, Ratjen F, editors. Cystic fibrosis (European Respiratory Monograph). European Respiratory Society Journals Ltd; 2006. pp. 66-78.
5. Brooke JS. Stenotrophomonas maltophilia: an emerging global opportunistic pathogen. Clin Microbiol Rev 2012; 25:2-41.
6. Goncalves-Vidigal P, Grosse-Onnebrink J, Mellies U, et al. Stenotrophomonas maltophiliain cysticfibrosis: improved detectionby the use of selective agar and evaluation of antimicrobial resistance. J Cyst Fibros 2011; 10:422-427.
7. Cescutti P, Cuzzi B, Liut G, et al. A novel highly charged exopolysaccharide produced by two strains of Stenotrophomonas maltophilia recovered from patients with cystic fibrosis. Carbohydr Res 2011; 346:1916-1923.
8. Pompilio A, Pomponio S, Crocetta V, et al. Phenotypic and genotypic characterization of Stenotrophomonas maltophilia isolates from patients with cystic fibrosis: genome diversity, biofilm formation, and virulence. BMC Microbiol 2011; 11:159.
9. Nicoletti M, Iacobino A, Prosseda G, Fiscarelli E, et al. Stenotrophomonas maltophilia strains from cystic fibrosis patients: genomic variability and molecular characterization of some virulence determinants. Int J Med Microbiol 2011; 301:34-43.
10. Dalboge CS, Hansen CR, Pressler T, Hoiby N, et al. Chronic pulmonary infection with Stenotrophomonas maltophilia and lung function in patients with cystic fibrosis. J Cyst Fibros 2011; 10:318-325.
11. Verregghen M, Heijerman HG, Reijers M, et al. Risk factors for Mycobacterium abscessus infection in cystic fibrosis patients: a case-control study. J Cyst Fibros 2012; 11:340-343.
12. Cystic Fibrosis Foundation. Patient Registry 2010 Annual Report 2012. http://www.cff.org/UploadedFiles/LivingWithCF/CareCenterNetwork/Patient Registry/2010-Patient-Registry-Report.pdf [Accessed May 2012]
13. Lee TW, Brownlee KG, Conway SP, et al. Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients. J Cyst Fibros 2003; 2:29-34.
14. Waters V, Yau Y, Prasad S, Lu A, et al. Stenotrophomonas maltophilia in cystic fibrosis: serologic response and effect on lung disease. Am J Respir Crit Care Med 2011; 183:635-640.
15. Waters V, Atenafu EG, Salazar JG, Lu A, et al. Chronic Stenotrophomonas maltophilia infection and exacerbation outcomes in cystic fibrosis. J Cyst Fibros 2012; 11:8-13.
16. Taccetti G, Bianchini E, Cariani L, et al. Early antibiotic treatment for Pseudomonas aeruginosa eradication in patients with cystic fibrosis: a randomised multicentre study comparing two different protocols. Thorax 2012. [Epub ahead of print]
17. Høiby N, Flensborg EW, Beck B, et al. Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of Pseudomonas aeruginosa precipitins determined by means of crossed immunoelectro-phoresis. Scand J Respir Dis 1977; 58:65-79.